These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 85367)
61. In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma. Kjaer M Eur J Cancer (1965); 1974 Aug; 10(8):523-31. PubMed ID: 4463002 [No Abstract] [Full Text] [Related]
62. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients. Murray E; McCarthy WH; Hersey P Br J Cancer; 1977 Jul; 36(1):7-14. PubMed ID: 19029 [TBL] [Abstract][Full Text] [Related]
63. Autogenous leukocyte migration in human malignancies. Elias EG; Elias LL Cancer; 1975 Oct; 36(4):1393-8. PubMed ID: 1175137 [TBL] [Abstract][Full Text] [Related]
64. Leukocyte migration studies in chronic myeloid leukemia (CML). Specificity of reactions. Gothoskar BP; D'Silva H; Gharpure H; Advani SH Eur J Cancer (1965); 1976 Oct; 12(10):815-21. PubMed ID: 61861 [No Abstract] [Full Text] [Related]
65. The effect of autologous serum, Oradexon and heparin on the cell-mediated immune response in vascular diseases. Horváth M; Szondy E; Ladányi A Clin Exp Immunol; 1980 Sep; 41(3):521-6. PubMed ID: 7438565 [TBL] [Abstract][Full Text] [Related]
66. Inhibition of leukocyte migration by human thyroid adenocarcinoma associated antigens. Aoki N; DeGroot LJ Acta Endocrinol (Copenh); 1982 Jan; 99(1):56-63. PubMed ID: 6174010 [No Abstract] [Full Text] [Related]
67. The immune reaction to human breast cancer: a comparison of skin and leucocyte migration tests. Roberts MM; Bathgate EM Br J Surg; 1975 Oct; 62(10):820-2. PubMed ID: 1191943 [TBL] [Abstract][Full Text] [Related]
68. Cell mediated immune reactions to autologous and homologous tumor tissue in cervical cancer patients. Koenig UD Obstet Gynecol Surv; 1979 Nov; 34(11):857-9. PubMed ID: 523041 [No Abstract] [Full Text] [Related]
69. Correlation between perchloric-acid-soluble serum proteins, cellular immunity and tumor-cell burden. Hakim AA Int J Cancer; 1980 Feb; 25(2):281-8. PubMed ID: 6248468 [No Abstract] [Full Text] [Related]
70. [Migration inhibition of mononuclear cells in idiopathic adrenal insufficiency. Inhibition of migration of mononuclear cells with adrenal microsomes and blocking of the reaction by adrenal antibodies (author's transl)]. Eibl M; Ludwig H; Schernthaner G; Erd W; Koller K; Mayr WR Klin Wochenschr; 1976 Jul; 54(13):619-24. PubMed ID: 940298 [TBL] [Abstract][Full Text] [Related]
71. Migration-inhibitory effect of serum from patients with prostatic cancer. Ablin RJ; Bruns GR; Guinan PD; Bush IM Oncology; 1974; 30(5):423-8. PubMed ID: 4142651 [TBL] [Abstract][Full Text] [Related]
72. [Leukocyte migration inhibition reaction--an index of the antibacterial effectiveness of stimulants of the body's nonspecific resistance]. Aptekareva MN; Sviridov LP Zh Mikrobiol Epidemiol Immunobiol; 1986 Jul; (7):100-2. PubMed ID: 3751402 [TBL] [Abstract][Full Text] [Related]
73. Leukocyte migration inhibition studies in sarcoidosis with evidence of a serum blocking factor. Rosling AE; Watson B; Rhodes EL Clin Exp Dermatol; 1977 Jun; 2(2):161-5. PubMed ID: 884895 [No Abstract] [Full Text] [Related]
74. Complement in leucocyte development and function. Regueiro JR; Fernández FJ; Vega MC Semin Cell Dev Biol; 2019 Jan; 85():84-85. PubMed ID: 29499387 [No Abstract] [Full Text] [Related]
75. [In vitro immune response of patient lymphocytes to live autologous tumor cells]. Grigor'eva MP; Kosmiadi GA; Govallo VI Vopr Onkol; 1980; 26(9):8-11. PubMed ID: 7423909 [TBL] [Abstract][Full Text] [Related]
76. Inhibition of leukocyte migration by tumor-associated antigen and its modification by serum; IgA as a blocking factor. Sipos J; Gábor V; Tóth Z Neoplasma; 1978; 25(2):181-8. PubMed ID: 643122 [TBL] [Abstract][Full Text] [Related]
77. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients]. Novikov DK; Borisenko ID; Shein IA Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731 [TBL] [Abstract][Full Text] [Related]
78. Common aspects of immunologic tolerance in pregnancy and malignancy. Gleicher N; Deppe G; Cohen CJ Obstet Gynecol; 1979 Sep; 54(3):335-42. PubMed ID: 382002 [TBL] [Abstract][Full Text] [Related]
79. [Mechanisms of the potentiating and blocking effects of the sera from tumor patients in the leukocyte migration inhibition reaction model]. Grigor'eva MP Vopr Onkol; 1979; 25(1):31-8. PubMed ID: 85367 [TBL] [Abstract][Full Text] [Related]